About Prostate Cancer - Understanding Progression

Boxing coach with prostate cancer from ERLEADA® (apalutamide) commercial coaching student

I HAVE PROSTATE
CANCER AND

I’m up for
the fight.

Learn about 2 types of prostate cancer

 

What is mCSPC?

Prostate cancer that HAS SPREAD to other parts of the body and STILL responds to a medical or surgical treatment that lowers testosterone. This is called metastatic castration-sensitive prostate cancer or mCSPC.

The most common sites where prostate cancer can spread are bones, adrenal gland, liver, and lungs.

 
 

What is nmCRPC?

Prostate cancer that HAS NOT SPREAD to other parts of the body and NO LONGER responds to a medical or surgical treatment that lowers testosterone. This is called non-metastatic castration-resistant prostate cancer or nmCRPC.

Prostate-specific antigen (PSA) is one of the ways your doctor may monitor your prostate cancer.

Often, PSA levels rise, which could be one of the indicators that the cancer may be progressing.

 
Prostate cancer can spread to other parts of the body.

Helpful Information and Resources

Patient and doctor during office visit discussing ERLEADA® (apalutamide)

Doctor Discussion Guide

Contains questions to help start a conversation with your doctor.

Download

Boxing coach with prostate cancer from ERLEADA® (apalutamide) commercial ringside

ERLEADA® Patient Brochure

Contains important information about mCSPC, nmCRPC, and ERLEADA®.

Download